These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Current medical aspects of pantethine. Horváth Z; Vécsei L Ideggyogy Sz; 2009 Jul; 62(7-8):220-9. PubMed ID: 19685700 [TBL] [Abstract][Full Text] [Related]
3. Effects of pantethine on in-vitro peroxidation of low density lipoproteins. Bon GB; Cazzolato G; Zago S; Avogaro P Atherosclerosis; 1985 Oct; 57(1):99-106. PubMed ID: 4074466 [TBL] [Abstract][Full Text] [Related]
4. [Pantethine, diabetes mellitus and atherosclerosis. Clinical study of 1045 patients]. Donati C; Bertieri RS; Barbi G Clin Ter; 1989 Mar; 128(6):411-22. PubMed ID: 2524328 [TBL] [Abstract][Full Text] [Related]
5. [Clinical use of pantethine by parenteral route in the treatment of hyperlipidemia]. Arsenio L; Bodria P; Bossi S; Lateana M; Strata A Acta Biomed Ateneo Parmense; 1987; 58(5-6):143-52. PubMed ID: 2970754 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of long-term treatment with pantethine in patients with dyslipidemia. Arsenio L; Bodria P; Magnati G; Strata A; Trovato R Clin Ther; 1986; 8(5):537-45. PubMed ID: 3094958 [TBL] [Abstract][Full Text] [Related]
7. Lowering effect of pantethine on plasma beta-thromboglobulin and lipids in diabetes mellitus. Eto M; Watanabe K; Chonan N; Ishii K Artery; 1987; 15(1):1-12. PubMed ID: 2963604 [TBL] [Abstract][Full Text] [Related]
8. [Effect of pantethine on post-heparin lipolytic activity and lipid peroxidation in the myocardium]. Kumerova AO; Silova AA; Utno LIa Biull Eksp Biol Med; 1991 Jan; 111(1):33-5. PubMed ID: 2054471 [TBL] [Abstract][Full Text] [Related]
9. [Comparison of the efficacy of pantethine, acipimox, and bezafibrate on plasma lipids and index of cardiovascular risk in diabetics with dyslipidemia]. Tonutti L; Taboga C; Noacco C Minerva Med; 1991 Oct; 82(10):657-63. PubMed ID: 1745376 [TBL] [Abstract][Full Text] [Related]
10. The effect of pantethine and ultraviolet-B radiation on the development of lenticular opacity in the emory mouse. Congdon NT; West ST; Duncan DT; Fisher DT; Vitale ST; Rieger KT; Urist JT; Hazelwood DT; Sanchez AT; Pham T; Cole L; McNaughton C Curr Eye Res; 2000 Jan; 20(1):17-24. PubMed ID: 10611711 [TBL] [Abstract][Full Text] [Related]
11. [Effects of soysterol, pantethine and dl-alpha-tocopheryl nicotinate on hyperlipemia in rats (author's transl)]. Nakayama S; Negishi K; Sakamoto K Nihon Yakurigaku Zasshi; 1981 Sep; 78(3):191-202. PubMed ID: 7327448 [No Abstract] [Full Text] [Related]
12. [Effects of pantethine on blood lipids]. Giannini SD; Forti N; Di Rienzo F; Campanari JC; Ziliotto EE Arq Bras Cardiol; 1986 Apr; 46(4):283-9. PubMed ID: 3548666 [No Abstract] [Full Text] [Related]
13. Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine. McCarty MF Med Hypotheses; 2001 Mar; 56(3):314-7. PubMed ID: 11359352 [TBL] [Abstract][Full Text] [Related]
14. [Cytochrome P-450-dependent reactions during intensified biosynthesis of coenzyme A in hepatocytes]. Sushko LI; Sheĭbak VM; Abakumov GZ; Moĭseenok AK Vopr Med Khim; 1986; 32(4):20-4. PubMed ID: 3765494 [TBL] [Abstract][Full Text] [Related]
15. [Effect of oral pantethine administration on blood acetaldehyde levels following alcohol ingestion]. Watamaba A; Yoshihara T; Kobayashi M; Nakatsukasa S; Nagashima H Nihon Shokakibyo Gakkai Zasshi; 1984 Dec; 81(12):3039. PubMed ID: 6530807 [No Abstract] [Full Text] [Related]
16. Influence of pantethine on platelet volume, microviscosity, lipid composition and functions in diabetes mellitus with hyperlipidemia. Hiramatsu K; Nozaki H; Arimori S Tokai J Exp Clin Med; 1981 Jan; 6(1):49-57. PubMed ID: 7256794 [TBL] [Abstract][Full Text] [Related]
17. [Use of pantethine in dyslipidemia of chronic uremic patients under dialysis treatment]. Bergesio F; Ciuti R; Innocenti D; Galli GA; Frizzi V G Clin Med; 1985; 66(11-12):433-40. PubMed ID: 3835087 [No Abstract] [Full Text] [Related]